TMPRSS2 shows no correlation or negative correlation with the factors that facilitate cancer progression in LUAD, setting an alert on targeting TMPRSS2 in comorbidity of COVID-19 and lung cancer. This evidence concerns the gene TMPRSS2 and lung carcinoma.